Latest News
Breaking news and real-time updates from the ASX small-cap market

Clean TeQ Water Wins Rasp Mine Tailings Dewatering Plant Contract from Broken Hill Mines
Clean TeQ Water wins design-build contract for ATA tailings dewatering at Rasp Mine, Broken Hill, enabling 750,000 tpa output and in-pit stacking by Q3 FY2027.

Racura Oncology Advances CPACS Trial to Next Dose Level
Racura Oncology advances RC220 CPACS trial to 80mg/m2 as SRC clears Cohort 2; updated cardioprotection protocol; A$19.38m cash runway to CY2027.

Resolution Minerals Begins Golden Gate Drilling as Gold Metallurgy Returns High Recoveries
Resolution Minerals kicks off 2026 Golden Gate drill program (up to 13,700m across 45 holes) as oxide gold recoveries reach 94-95% in tests (ASX:RML).

Archer Materials Advances Biosensor Prototype Toward Preclinical Validation
Archer Materials advances its Biosensor beta prototype toward preclinical validation, targeting external testing and 2027 clinical trials with IMEC collaboration.

Xreality Group Launches MR-1 with First Commercial Sale as US DoD Project Reaches Completion
xReality completes DoD subcontract, launches MR-1 with first sale; Operator XR ARR hits AU$7m as pipeline grows to AU$74m—de-risking growth for investors.

Carnegie Clean Energy Receives EuropeWave Phase 3 Milestone Payment
Carnegie Clean Energy hits EuropeWave milestone: €63,688 (~A$103k) after BiMEP Spain approvals, boosting CETO deployment in Europe.

SPC Global Holdings Launches $100m Raising to Cut Debt and Reset Balance Sheet
SPC Global launches a $100m equity raise to cut debt and reset its balance sheet, targeting leverage down to 1.1x as it accelerates its execution plan.

Hydrix Wins Key Counter-Drone Contract with NIOA Group
Hydrix wins $1-1.2m counter-drone contract with NIOA; ramp from May 2026, milestones to 2027, amid AREO capital raise and trading halt.

Argenica Therapeutics Establishes Expert Committee to Advance Phase 2b Stroke Trial
Argenica Therapeutics forms Clinical Advisory Committee to accelerate ARG-007 Phase 2b stroke trial.

Euro Manganese Delivers Positive Chvaletice Assessment with Phased Development Pathway
Euro Manganese delivers positive Chvaletice PEA; post-tax NPV $492m, IRR 13.8%, payback 7.3y; phased 150ktpa HPMSM plan; feasibility by H1 2027.

EV Resources Advances Tecomatlán Antimony Plant with Mill Commissioning and Feedstock Deal
EV Resources advances Tecomatlán antimony plant with dry-mill commissioning and a third-party feedstock MoU, aiming for first concentrate in H2 2026.

Bapcor Lowers FY26 Earnings Guidance Despite Turnaround Momentum
Bapcor trims FY26 guidance as turnaround gains momentum, capping EBITDA at $144-150m post-AASB16 amid tougher trading conditions.